Temporal Changes of Spinal Microglia in Murine Models of Neuropathic Pain: a Scoping Review

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Dec 30

PMID 39735541

Authors

Simran Dhir

Hannah Derue

Alfredo Ribeiro-da-Silva

Affiliations

Soon will be listed here.

Abstract

Neuropathic pain (NP) is an ineffectively treated, debilitating chronic pain disorder that is associated with maladaptive changes in the central nervous system, particularly in the spinal cord. Murine models of NP looking at the mechanisms underlying these changes suggest an important role of microglia, the resident immune cells of the central nervous system, in various stages of disease progression. However, given the number of different NP models and the resource limitations that come with tracking longitudinal changes in NP animals, many studies fail to truly recapitulate the patterns that exist between pain conditions and temporal microglial changes. This review integrates how NP studies are being carried out in murine models and how microglia changes over time can affect pain behavior in order to inform better study design and highlight knowledge gaps in the field. 258 peer-reviewed, primary source articles looking at spinal microglia in murine models of NP were selected using Covidence. Trends in the type of mice, statistical tests, pain models, interventions, microglial markers and temporal pain behavior and microglia changes were recorded and analyzed. Studies were primarily conducted in inbred, young adult, male mice having peripheral nerve injury which highlights the lack of generalizability in the data currently being collected. Changes in microglia and pain behavior, which were both increased, were tested most commonly up to 2 weeks after pain initiation despite aberrant microglia activity also being recorded at later time points in NP conditions. Studies using treatments that decrease microglia show decreased pain behavior primarily at the 1- and 2-week time point with many studies not recording pain behavior despite the involvement of spinal microglia dysfunction in their development. These results show the need for not only studying spinal microglia dynamics in a variety of NP conditions at longer time points but also for better clinically relevant study design considerations.

References

Almeida C, DeMaman A, Kusuda R, Cadetti F, Ravanelli M, Queiroz A . Exercise therapy normalizes BDNF upregulation and glial hyperactivity in a mouse model of neuropathic pain. Pain. 2015; 156(3):504-513. DOI: 10.1097/01.j.pain.0000460339.23976.12. View

Lee S, Wu Y, Shi X, Zhang J . Characteristics of spinal microglia in aged and obese mice: potential contributions to impaired sensory behavior. Immun Ageing. 2015; 12:22. PMC: 4657254. DOI: 10.1186/s12979-015-0049-5. View

Lee S, Shi X, Fan A, West B, Zhang J . Targeting macrophage and microglia activation with colony stimulating factor 1 receptor inhibitor is an effective strategy to treat injury-triggered neuropathic pain. Mol Pain. 2018; 14:1744806918764979. PMC: 5858622. DOI: 10.1177/1744806918764979. View

Choi S, Beitz A, Lee J . Inhibition of cytochrome P450c17 reduces spinal astrocyte activation in a mouse model of neuropathic pain via regulation of p38 MAPK phosphorylation. Biomed Pharmacother. 2019; 118:109299. DOI: 10.1016/j.biopha.2019.109299. View

Hirai T, Uchida K, Nakajima H, Guerrero A, Takeura N, Watanabe S . The prevalence and phenotype of activated microglia/macrophages within the spinal cord of the hyperostotic mouse (twy/twy) changes in response to chronic progressive spinal cord compression: implications for human cervical compressive myelopathy. PLoS One. 2013; 8(5):e64528. PMC: 3663759. DOI: 10.1371/journal.pone.0064528. View

Kosaka Y, Yafuso T, Shimizu-Okabe C, Kim J, Kobayashi S, Okura N . Development and persistence of neuropathic pain through microglial activation and KCC2 decreasing after mouse tibial nerve injury. Brain Res. 2020; 1733:146718. DOI: 10.1016/j.brainres.2020.146718. View

Herder V, Iskandar C, Kegler K, Hansmann F, Elmarabet S, Khan M . Dynamic Changes of Microglia/Macrophage M1 and M2 Polarization in Theiler's Murine Encephalomyelitis. Brain Pathol. 2014; 25(6):712-23. PMC: 8029129. DOI: 10.1111/bpa.12238. View

Evans T, Barkauskas D, Myers J, Hare E, You J, Ransohoff R . High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury. Exp Neurol. 2014; 254:109-20. PMC: 3954731. DOI: 10.1016/j.expneurol.2014.01.013. View

Ghasemi A, Zahediasl S . Normality tests for statistical analysis: a guide for non-statisticians. Int J Endocrinol Metab. 2013; 10(2):486-9. PMC: 3693611. DOI: 10.5812/ijem.3505. View

10.

Poznanski P, Giebultowicz J, Durdzinska J, Kocki T, Sacharczuk M, Bujalska-Zadrozny M . Mechanisms Underlining Inflammatory Pain Sensitivity in Mice Selected for High and Low Stress-Induced Analgesia-The Role of Endocannabinoids and Microglia. Int J Mol Sci. 2022; 23(19). PMC: 9570076. DOI: 10.3390/ijms231911686. View

11.

Ishii H, Tanabe S, Ueno M, Kubo T, Kayama H, Serada S . ifn-γ-dependent secretion of IL-10 from Th1 cells and microglia/macrophages contributes to functional recovery after spinal cord injury. Cell Death Dis. 2013; 4:e710. PMC: 3730408. DOI: 10.1038/cddis.2013.234. View

12.

Tonkin R, Bowles C, Perera C, Keating B, Makker P, Duffy S . Attenuation of mechanical pain hypersensitivity by treatment with Peptide5, a connexin-43 mimetic peptide, involves inhibition of NLRP3 inflammasome in nerve-injured mice. Exp Neurol. 2017; 300:1-12. DOI: 10.1016/j.expneurol.2017.10.016. View

13.

Honjoh K, Nakajima H, Hirai T, Watanabe S, Matsumine A . Relationship of Inflammatory Cytokines From M1-Type Microglia/Macrophages at the Injured Site and Lumbar Enlargement With Neuropathic Pain After Spinal Cord Injury in the CCL21 Knockout () Mouse. Front Cell Neurosci. 2019; 13:525. PMC: 6881269. DOI: 10.3389/fncel.2019.00525. View

14.

Huang Y, Hao J, Yang X, Xu L, Liu Y, Sun Y . Pretreatment of the ROS Inhibitor Phenyl-N-tert-butylnitrone Alleviates Sleep Deprivation-Induced Hyperalgesia by Suppressing Microglia Activation and NLRP3 Inflammasome Activity in the Spinal Dorsal Cord. Neurochem Res. 2022; 48(1):305-314. PMC: 9823061. DOI: 10.1007/s11064-022-03751-5. View

15.

Isami K, Imai S, Sukeishi A, Nagayasu K, Shirakawa H, Nakagawa T . The impact of mouse strain-specific spatial and temporal immune responses on the progression of neuropathic pain. Brain Behav Immun. 2018; 74:121-132. DOI: 10.1016/j.bbi.2018.08.013. View

16.

Bogacka J, Ciapala K, Pawlik K, Kwiatkowski K, Dobrogowski J, Przeklasa-Muszynska A . CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain. Front Immunol. 2020; 11:1241. PMC: 7372009. DOI: 10.3389/fimmu.2020.01241. View

17.

Tansley S, Uttam S, Urena Guzman A, Yaqubi M, Pacis A, Parisien M . Single-cell RNA sequencing reveals time- and sex-specific responses of mouse spinal cord microglia to peripheral nerve injury and links ApoE to chronic pain. Nat Commun. 2022; 13(1):843. PMC: 8837774. DOI: 10.1038/s41467-022-28473-8. View

18.

Radulescu C, Cerar V, Haslehurst P, Kopanitsa M, Barnes S . The aging mouse brain: cognition, connectivity and calcium. Cell Calcium. 2021; 94:102358. DOI: 10.1016/j.ceca.2021.102358. View

19.

Tateda S, Kanno H, Ozawa H, Sekiguchi A, Yahata K, Yamaya S . Rapamycin suppresses microglial activation and reduces the development of neuropathic pain after spinal cord injury. J Orthop Res. 2016; 35(1):93-103. DOI: 10.1002/jor.23328. View

20.

Teixeira-Santos L, Martins S, Sousa T, Albino-Teixeira A, Pinho D . The pro-resolving lipid mediator Maresin 1 ameliorates pain responses and neuroinflammation in the spared nerve injury-induced neuropathic pain: A study in male and female mice. PLoS One. 2023; 18(6):e0287392. PMC: 10286986. DOI: 10.1371/journal.pone.0287392. View